Latest news

Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings:

SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma Pharmaceuticals shares fell 3.8% to close at $5.36 on Friday.

Cantor Fitzgerald raised Tilray Brands, Inc. (NASDAQ: TLRY) price target from $4.15 to $4.5. Cantor Fitzgerald analyst Pablo Zuanic maintained a Neutral rating on the stock. Tilray Brands shares fell 2.5% to $3.09 in pre-market trading.

  On Tuesday, 456 stocks hit new 52-week lows.

  Monday saw 825 companies set new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

Some real estate investment trusts (REITs) are hitting new year-to-date lows as the effects of Fed Chair Jerome Powell’s hawkish remarks at this year’s Jackson Hole, Wyoming, retreat sink in.

Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter:

Morgan Stanley analyst Richard Hill maintains Ventas (NYSE:VTR) with a Equal-Weight and raises the price target from $52 to $54.

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.